{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T00:15:16Z","timestamp":1772928916111,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"DOI":"10.1007\/s12013-025-01943-8","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T10:36:03Z","timestamp":1762425363000},"page":"1281-1287","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reprogramming PBMC Bioenergetics Via Phosphoglucomutase 1 Modulation in Type 2 Diabetes: Unveiling a Glycogen\u2013Immune Axis"],"prefix":"10.1007","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3754-1401","authenticated-orcid":false,"given":"Praveen","family":"Kumar K. S","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prabhakar","family":"Kamarthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharath","family":"Balakrishna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"issue":"7640","key":"1943_CR1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature21363","volume":"542","author":"GS Hotamisligil","year":"2017","unstructured":"Hotamisligil, G. S. (2017). Inflammation, metaflammation and immunometabolic disorders. Nature, 542(7640), 177\u2013185.","journal-title":"Nature"},{"issue":"3","key":"1943_CR2","first-page":"100952","volume":"5","author":"MJ Kraakman","year":"2024","unstructured":"Kraakman, M. J., Lee, M. K., et al. (2024). Immunometabolism and its relevance to metabolic disease. Cell Rep Med, 5(3), 100952.","journal-title":"Cell Rep Med"},{"issue":"1","key":"1943_CR3","first-page":"21","volume":"23","author":"LAJ O\u2019Neill","year":"2023","unstructured":"O\u2019Neill, L. A. J., Kishton, R. J., & Rathmell, J. (2023). A guide to immunometabolism for immunologists. Nature Reviews Immunology, 23(1), 21\u201344.","journal-title":"Nature Reviews Immunology"},{"issue":"2","key":"1943_CR4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3390\/nu16020245","volume":"16","author":"MM Adeva-Andany","year":"2024","unstructured":"Adeva-Andany, M. M., Fernandez-Fernandez, C., et al. (2024). Glycogen metabolism in humans. Nutrients, 16(2), 245.","journal-title":"Nutrients"},{"key":"1943_CR5","first-page":"1167783","volume":"14","author":"GZ Jin","year":"2023","unstructured":"Jin, G. Z., Ma, M., et al. (2023). Structural and functional insights into phosphoglucomutase family enzymes. Frontiers in Endocrinology, 14, 1167783.","journal-title":"Frontiers in Endocrinology"},{"issue":"1","key":"1943_CR6","first-page":"102","volume":"47","author":"S Radenkovic","year":"2024","unstructured":"Radenkovic, S., Rosengren, A., et al. (2024). Phosphoglucomutase deficiency: Expanding the clinical spectrum. Journal of Inherited Metabolic Disease, 47(1), 102\u2013110.","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"5","key":"1943_CR7","first-page":"e172345","volume":"134","author":"M Kim","year":"2024","unstructured":"Kim, M., et al. (2024). Epigenetic modulation of immunometabolism in diabetes. J Clin Invest, 134(5), e172345.","journal-title":"J Clin Invest"},{"issue":"2","key":"1943_CR8","first-page":"209","volume":"67","author":"GP Fadini","year":"2024","unstructured":"Fadini, G. P., Morieri, M. L., et al. (2024). Immune dysfunction and metabolic disease. Diabetologia, 67(2), 209\u2013222.","journal-title":"Diabetologia"},{"issue":"1","key":"1943_CR9","first-page":"12","volume":"29","author":"FS Manoel-Caetano","year":"2024","unstructured":"Manoel-Caetano, F. S., Martinez, M. B., et al. (2024). PBMC-based biomarkers for chronic diseases: Where do we stand?. Molecular Medicine Reports, 29(1), 12\u201320.","journal-title":"Molecular Medicine Reports"},{"issue":"8012","key":"1943_CR10","first-page":"165","volume":"630","author":"MI McCarthy","year":"2024","unstructured":"McCarthy, M. I. (2024). Precision medicine in diabetes: Progress and prospects. Nature, 630(8012), 165\u2013174.","journal-title":"Nature"},{"key":"1943_CR11","first-page":"1194581","volume":"16","author":"H Zhou","year":"2025","unstructured":"Zhou, H., et al. (2025). Post-translational regulation of immune cell metabolism in diabetes. Frontiers in Immunology, 16, 1194581.","journal-title":"Frontiers in Immunology"},{"issue":"8","key":"1943_CR12","first-page":"112345","volume":"42","author":"M van der Sande","year":"2023","unstructured":"van der Sande, M., et al. (2023). Control of immune metabolism through chromatin remodeling. Cell Rep, 42(8), 112345.","journal-title":"Cell Rep"},{"issue":"3","key":"1943_CR13","first-page":"150","volume":"20","author":"N Esser","year":"2024","unstructured":"Esser, N., et al. (2024). Immunometabolic checkpoints in chronic disease. Nature Reviews. Endocrinology, 20(3), 150\u2013163.","journal-title":"Nature Reviews. Endocrinology"},{"issue":"6","key":"1943_CR14","doi-asserted-by":"publisher","first-page":"394","DOI":"10.7326\/M18-1149","volume":"169","author":"G Roglic","year":"2018","unstructured":"Roglic, G., & Norris, S. L. (2018). Medicines for Treatment Intensification in Type 2 Diabetes and Type of Insulin in Type 1 and Type 2 Diabetes in Low-Resource Settings: Synopsis of the World Health Organization Guidelines on Second- and Third-Line Medicines and Type of Insulin for the Control of Blood Glucose Levels in Nonpregnant Adults With Diabetes Mellitus. Annals of internal medicine, 169(6), 394\u2013397.","journal-title":"Annals of internal medicine"},{"issue":"3","key":"1943_CR15","first-page":"329","volume":"6","author":"R Mallone","year":"2011","unstructured":"Mallone, R., Mannering, S. I., et al. (2011). Isolation of peripheral blood mononuclear cells. Nature Protocols, 6(3), 329\u2013338.","journal-title":"Nature Protocols"},{"key":"1943_CR16","doi-asserted-by":"crossref","unstructured":"Strober, W. (2015). Trypan blue exclusion test of cell viability. Curr Protoc Immunol. ;111:A3.B.1\u2013A3.B.3.","DOI":"10.1002\/0471142735.ima03bs111"},{"issue":"1","key":"1943_CR17","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","volume":"150","author":"PK Smith","year":"1985","unstructured":"Smith, P. K., Krohn, R. I., et al. (1985). Measurement of protein using bicinchoninic acid. Analytical Biochemistry, 150(1), 76\u201385.","journal-title":"Analytical Biochemistry"},{"issue":"1","key":"1943_CR18","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","volume":"162","author":"P Chomczynski","year":"1993","unstructured":"Chomczynski, P., & Sacchi, N. (1993). Single-step RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry, 162(1), 156\u2013159.","journal-title":"Analytical Biochemistry"},{"issue":"4","key":"1943_CR19","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J., & Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR. Methods, 25(4), 402\u2013408.","journal-title":"Methods"},{"issue":"1","key":"1943_CR20","first-page":"e1234","volume":"6","author":"AC Codo","year":"2024","unstructured":"Codo, A. C., et al. (2024). Glycogen stores and immune responses. Immunometab, 6(1), e1234.","journal-title":"Immunometab"},{"key":"1943_CR21","doi-asserted-by":"publisher","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","volume":"157","author":"P Saeedi","year":"2023","unstructured":"Saeedi, P., Petersohn, I., et al. (2023). Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045. Diabetes Research and Clinical Practice, 157, 107843.","journal-title":"Diabetes Research and Clinical Practice"},{"key":"1943_CR22","first-page":"129","volume":"42","author":"NJ MacIver","year":"2024","unstructured":"MacIver, N. J., Michalek, R. D., & Rathmell, J. C. (2024). Metabolic regulation of T lymphocytes. Annual Review of Immunology, 42, 129\u2013158.","journal-title":"Annual Review of Immunology"},{"issue":"4","key":"1943_CR23","first-page":"285","volume":"20","author":"MY Donath","year":"2024","unstructured":"Donath, M. Y., & Shoelson, S. E. (2024). Type 2 diabetes as an inflammatory disease. Nature Reviews Immunology, 20(4), 285\u2013295.","journal-title":"Nature Reviews Immunology"},{"key":"1943_CR24","first-page":"1002234","volume":"15","author":"S Ferlita","year":"2024","unstructured":"Ferlita, S., et al. (2024). Immunometabolic dysregulation and infection risk in diabetes. Frontiers in Immunology, 15, 1002234.","journal-title":"Frontiers in Immunology"},{"issue":"2","key":"1943_CR25","first-page":"112","volume":"35","author":"F Marangoni","year":"2024","unstructured":"Marangoni, F., et al. (2024). PBMC transcriptomics in type 2 diabetes: A new frontier. Trends in Endocrinology and Metabolism, 35(2), 112\u2013119.","journal-title":"Trends in Endocrinology and Metabolism"},{"key":"1943_CR26","first-page":"123","volume":"17","author":"X Zhang","year":"2024","unstructured":"Zhang, X., et al. (2024). Biomarkers of immune metabolism in diabetes. Diabetes Metab Syndr Obes, 17, 123\u2013135.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"1943_CR27","first-page":"155287","volume":"145","author":"Y He","year":"2024","unstructured":"He, Y., et al. (2024). Novel strategies to restore immune cell bioenergetics in type 2 diabetes. Metabolism, 145, 155287.","journal-title":"Metabolism"},{"key":"1943_CR28","doi-asserted-by":"crossref","first-page":"987654","DOI":"10.3389\/fendo.2024.1456305","volume":"15","author":"S Khan","year":"2024","unstructured":"Khan, S., et al. (2024). Nutritional immunometabolism in diabetes. Frontiers in Endocrinology, 15, 987654.","journal-title":"Frontiers in Endocrinology"},{"issue":"4","key":"1943_CR29","first-page":"256","volume":"23","author":"MG Netea","year":"2023","unstructured":"Netea, M. G., et al. (2023). Trained immunity and its relevance to chronic diseases. Nature Reviews Immunology, 23(4), 256\u2013269.","journal-title":"Nature Reviews Immunology"},{"issue":"3","key":"1943_CR30","first-page":"200","volume":"45","author":"RJW Arts","year":"2024","unstructured":"Arts, R. J. W., et al. (2024). Epigenetic reprogramming of innate immunity in metabolic disease. Trends in Immunology, 45(3), 200\u2013212.","journal-title":"Trends in Immunology"},{"issue":"4","key":"1943_CR31","first-page":"671","volume":"36","author":"S Bekkering","year":"2024","unstructured":"Bekkering, S., et al. (2024). Immunometabolism of trained immunity. Cell Metab, 36(4), 671\u2013682.","journal-title":"Cell Metab"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01943-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-025-01943-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01943-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T04:46:48Z","timestamp":1772858808000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-025-01943-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["1943"],"URL":"https:\/\/doi.org\/10.1007\/s12013-025-01943-8","relation":{},"ISSN":["1559-0283"],"issn-type":[{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]},"assertion":[{"value":"31 October 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Ethics Committee, Sri Devaraj Urs Medical College, Kolar (Ref: SDUMC\/KLR\/IEC\/30\/2019-20). The study protocol was approved by the Institutional Ethics Committee of Sri Devaraj Urs Academy of Higher Education and Research, Tamaka, Kolar. All procedures were conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Ethics Approval"}},{"value":"Written informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}